HDAC-IN-77
HDAC-IN-77 (HL-5s) is an HDAC inhibitor. HDAC-IN-77 can induce ferroptosis and inhibit the Nrf2/HO-1 signaling pathway. HDAC-IN-77 can be used in cancer research.
For research use only. We do not sell to patients.
- Formula: C22H26N4O2S
- Molecular Weight:410.53
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
1.84 μM
Compound: HL-5s
|
Antiproliferative activity against human A549 cells incubated for 24 to 48 hrs by CCK-8 assay
Antiproliferative activity against human A549 cells incubated for 24 to 48 hrs by CCK-8 assay
|
[PMID: 39145486] |
| HeLa | IC50 |
1.09 μM
Compound: HL-5s
|
Antiproliferative activity against human HeLa cells incubated for 24 to 48 hrs by CCK-8 assay
Antiproliferative activity against human HeLa cells incubated for 24 to 48 hrs by CCK-8 assay
|
[PMID: 39145486] |
| Jurkat | IC50 |
1.54 μM
Compound: HL-5s
|
Antiproliferative activity against human Jurkat cells incubated for 24 to 48 hrs by CCK-8 assay
Antiproliferative activity against human Jurkat cells incubated for 24 to 48 hrs by CCK-8 assay
|
[PMID: 39145486] |
| MDA-MB-231 | IC50 |
0.9 μM
Compound: HL-5s
|
Antiproliferative activity against human MDA-MB-231 cells incubated for 24 to 48 hrs by CCK-8 assay
Antiproliferative activity against human MDA-MB-231 cells incubated for 24 to 48 hrs by CCK-8 assay
|
[PMID: 39145486] |
| PC-9 | IC50 |
0.18 μM
Compound: HL-5s
|
Antiproliferative activity against human PC-9 cells incubated for 24 to 48 hrs by CCK-8 assay
Antiproliferative activity against human PC-9 cells incubated for 24 to 48 hrs by CCK-8 assay
|
[PMID: 39145486] |
| THP-1 | IC50 |
0.41 μM
Compound: HL-5s
|
Antiproliferative activity against human THP-1 cells incubated for 24 to 48 hrs by CCK-8 assay
Antiproliferative activity against human THP-1 cells incubated for 24 to 48 hrs by CCK-8 assay
|
[PMID: 39145486] |
Chemical Information
-
Molecular Weight 410.53
-
Formula C22H26N4O2S
-
SMILES
O=C(/C=C/C1=CC=C(CSC2=NC3=CC=CC=C3N2CCCN(C)C)C=C1)NO
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)